U.S. Blood Testing Market Size & Outlook, 2023-2030
U.S. blood testing market, 2018-2030 (US$M)
Related Markets
U.S. blood testing market highlights
- The U.S. blood testing market generated a revenue of USD 36,844.7 million in 2023 and is expected to reach USD 56,866.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, glucose testing was the largest revenue generating test type in 2023.
- Glucose testing is the most lucrative test type segment registering the fastest growth during the forecast period.
Blood testing market data book summary
| Market revenue in 2023 | USD 36,844.7 million |
| Market revenue in 2030 | USD 56,866.2 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Glucose testing |
| Fastest growing segment | Glucose testing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.4% of the global blood testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. blood testing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 9,471.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Testing Market Scope
Blood Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. blood testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood testing market will help companies and investors design strategic landscapes.
Glucose testing was the largest segment with a revenue share of 15.36% in 2023. Horizon Databook has segmented the U.S. blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. witnessed exponential market growth due to the presence of major market players, welldeveloped healthcare infrastructure, and increase in R&D in the country. Moreover, increasing adoption of innovative, advanced technology and high focus on clinical research in this region are driving the market growth.
The number of surgeries has increased globally, which can be attributed to the rise in incidence of severe chronic diseases and accidents. Increase in the prevalence of target diseases is a major factor anticipated to fuel the market growth during the forecast period.
According to the American Cancer Society, prostate cancer is the second most diagnosed cancer in the U.S. and the third leading cause of death in men. Estimates from the same source also indicate that 1 in 41 men in the U.S. will die as a result of prostate cancer.
Reasons to subscribe to U.S. blood testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. blood testing market databook
-
Our clientele includes a mix of blood testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. blood testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. blood testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. blood testing market size, by test type, 2018-2030 (US$M)
U.S. Blood Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
